Kintegral Advisory’s Johnson & Johnson JNJ Stock Holding History

Kintegral Advisory’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-110,403	Closed	-$6.69M	–	263
2023 Q1	$6.69M	Buy	+110,403	New	+$17.8M	0.86%	26
2022 Q4	–	Sell	-31,503	Closed	-$5.15M	–	292
2022 Q3	$5.15M	Hold	31,503	–	–	0.71%	28
2022 Q2	$5.59M	Buy	31,503 +667	+2%	+$119K	0.73%	30
2022 Q1	$5.46M	Buy	30,836 +690	+2%	+$117K	0.6%	34
2021 Q4	$5.16M	Hold	30,146	–	–	0.53%	43
2021 Q3	$4.87M	Hold	30,146	–	–	0.57%	38
2021 Q2	$4.97M	Hold	30,146	–	–	0.59%	37
2021 Q1	$4.95M	Hold	30,146	–	–	0.64%	37
2020 Q4	$4.74M	Hold	30,146	–	–	0.64%	35
2020 Q3	$4.49M	Sell	30,146 -970	-3%	-$144K	0.68%	34
2020 Q2	$4.38M	Hold	31,116	–	–	0.7%	33
2020 Q1	$4.08M	Buy	31,116 +3,481	+13%	+$494K	0.79%	30
2019 Q4	$4.03M	Hold	27,635	–	–	0.73%	33
2019 Q3	$3.58M	Hold	27,635	–	–	0.71%	35
2019 Q2	$3.85M	Hold	27,635	–	–	0.78%	29
2019 Q1	$3.86M	Sell	27,635 -108	-0.4%	-$14.5K	0.81%	25
2018 Q4	$3.58M	Buy	+27,743	New	+$3.87M	1.06%	24

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Kintegral Advisory's JNJ Position: Q2 2023 in Review

Kintegral Advisory sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 110,403 shares — an estimated $6.69M sold.

Kintegral Advisory first reported a position in JNJ in Q4 2018 and held it in 17 quarters. The position peaked at $6.69M in Q1 2023. 3,751 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

Kintegral Advisory reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
Kintegral Advisory sold 110,403 Johnson & Johnson shares in Q2 2023, an estimated $6.69M.
Kintegral Advisory first reported a position in Johnson & Johnson in Q4 2018 and held it in 17 quarters.
Kintegral Advisory's Johnson & Johnson position peaked at $6.69M in Q1 2023.
3,751 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on Kintegral Advisory's 13F filing for Q2 2023, filed 2 Aug 2023.